(Q51825004)

13 April 2018

title

Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. (English)

1 reference

13 April 2018

main subject

myocardial infarction

1 reference

based on heuristic

inferred from title

author

Gunnar Hilmar Gislason

1

1 reference

13 April 2018

Christian Torp-Pedersen

11

Christian Torp-Pedersen

1 reference

13 April 2018

8

Lars Køber

1 reference

13 April 2018

3

Steen Z Abildstrøm

1 reference

13 April 2018

Niels Gadsbøll

4

Niels Gadsbøll

1 reference

13 April 2018

Jeppe Have Rasmussen

2

Jeppe N Rasmussen

1 reference

13 April 2018

Pernille Buch

5

Pernille Buch

1 reference

13 April 2018

Jens Friberg

6

Jens Friberg

1 reference

13 April 2018

Steen Stender

9

Steen Stender

1 reference

13 April 2018

author name string

Søren Rasmussen

7

1 reference

13 April 2018

Mette Madsen

10

1 reference

13 April 2018

publication date

6 January 2006

1 reference

13 April 2018

published in

European Heart Journal

1 reference

13 April 2018

volume

27

1 reference

13 April 2018

issue

10

1 reference

13 April 2018

page(s)

1153-1158

1 reference

13 April 2018

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

Statin use after acute myocardial infarction: a nationwide study in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

High persistence of statin use in a Danish population: compliance study 1993-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

Adherence with statin therapy in secondary prevention of coronary heart disease in veterans administration male population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

Cardiovascular drug class specificity: beta-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

European healthcare policies for controlling drug expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

Changes in hospitalization rate and mortality after acute myocardial infarction in Denmark after diagnostic criteria and methods changed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI705

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHI705

1 reference

13 April 2018

1 reference

13 April 2018